Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x100px

Person › Details

Axel Mescheder (Cristal Delivery B.V. (d/b/a/ Cristal Therapeutics))

Mescheder, Axel (Cristal Therapeutics 201811– CEO + CMO before MorphoSys/Lanthio + Medpace + TopoTarget + Medigene)

	Organisation	Cristal Delivery B.V. (d/b/a/ Cristal Therapeutics)
	Former/major organisation	Lanthio Pharma B.V.
	Group	Novartis (Group)
	Product	CriPec® nanoparticle drug delivery platform
	Product 2	CPC634 (Cristal Therapeutics)

Record changed: 2021-05-18

Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x200px

More documents for Axel Mescheder

[1] Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/6/21). "Press Release: Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms". Bilthoven & Maastricht....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]